Dallas Formulations Private Limited

Dallas Formulations Private Limited - pharma in Ujjain, Madhya Pradesh, India. FY 2026 financials and compliance.
CIN U24233MP2000PTC014476 Incorporated 24 November 2000 ROC Gwalior HQ Ujjain, Madhya Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹10.53 Cr
▲ 47.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹39.09 Lakh
Issued & subscribed
Open charges
₹2.66 Cr
Satisfied ₹5.24 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
22
Latest available

About Dallas Formulations Private Limited

Data last updated: 18 December 2025

Dallas Formulations Private Limited is a private limited company based in Ujjain, Madhya Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 November 2000, the company has been in operation for over 26 years.

Registered with ROC Gwalior under CIN U24233MP2000PTC014476.

Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹39.09 Lakh. Formerly known as Chirayu Ayurveda Private Limited. It is led by directors Rajesh Gupta and Mukesh Kumar.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 220 Block – C 2Nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010.

As per the financials filed for FY 2025, the company reported a revenue of ₹10.53 Cr, a growth of 47% compared to the previous year.

The company has a workforce of approximately 22 employees as per the latest available data.

The company is associated with 1 brand - Dallas Formulations. As per MCA filings, the company has open charges of ₹2.66 Cr and satisfied charges of ₹5.24 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dallaspharma.com.

Company Details of Dallas Formulations Private Limited
CIN U24233MP2000PTC014476
Registration Number 014476
Incorporation Date 24 November 2000
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    220 Block – C 2Nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010
  • Industry
    Pharma, Drug Formulation & Development
Company report
Dallas Formulations Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Dallas Formulations Private Limited report

Financials, compliance, directors, charges, ownership and filings for Dallas Formulations Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Dallas Formulations Private Limited

Dallas Formulations Private Limited operates one associated brand: Dallas Formulations. These brands represent Dallas Formulations Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures pharmaceutical tablets, capsules, and injectables for health markets. dallaspharma.com

Competitors & Alternatives of Dallas Formulations Private Limited

Brands and companies operating in the same space as Dallas Formulations Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
MedPharm MedPharm Topical and inhaled drug delivery formulations are developed and manufactured. Guildford, United Kingdom, United Kingdom 1998

Business Activity of Dallas Formulations Private Limited

Dallas Formulations Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Dallas Formulations Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Dallas Formulations Private Limited

Dallas Formulations Private Limited is audited by V.K. Ladha & Associates for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
V.K. Ladha & Associates Locked Locked Locked
Premium access

Complete auditor history for Dallas Formulations Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Dallas Formulations Private Limited

Dallas Formulations Private Limited is currently managed by 2 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rajesh Gupta Director 16 Jan 2006 20 Years 7 Months Current
Mukesh Kumar Whole-Time Director 21 Jul 2022 4 Years 0 Months Current

Financials of Dallas Formulations Private Limited FY 2024 filings available

Dallas Formulations Private Limited reported revenue of ₹10.53 Cr (up 47.00% YoY) for FY 2025.

Revenue · FY 2025
₹10.53 Cr ▲ 47.00%
Premium access

Ten-year financial statements for Dallas Formulations Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Dallas Formulations Private Limited

Premium access

Shareholding and ownership data for Dallas Formulations Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Dallas Formulations Private Limited

Open charges
₹2.66 Cr
Satisfied charges
₹5.24 Cr
Breakdown by lending institutions
State Bank of India₹2.66 Cr
Latest charge details
DateLenderAmountStatus
11 Nov 2006 State Bank of India ₹2.66 Cr Open
28 Nov 2013 Ing Vysya Bank Limited ₹1.75 Cr Satisfied
17 Aug 2011 Dir. of Industries with Parri Passu Sbi Baddi ₹1.29 Cr Satisfied
29 Apr 2006 State Bank of India ₹2.2 Cr Satisfied

Total charge records: 4 View all charges

Employees and EPFO Compliance at Dallas Formulations Private Limited

Dallas Formulations Private Limited has a workforce of 22 employees as of Mar 24, 2025.

Employee count
22
Active EPFO establishments
1
Employee growth
-15.38%
Premium access

Employee and EPFO history for Dallas Formulations Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Dallas Formulations Private Limited

Premium access

GST registrations and filing compliance for Dallas Formulations Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Dallas Formulations Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Dallas Formulations Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Dallas Formulations Private Limited

Premium access

MSME payment history for Dallas Formulations Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Dallas Formulations Private Limited

Premium access

Corporate group structure for Dallas Formulations Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Dallas Formulations Private Limited

Premium access

MCA filings and documents for Dallas Formulations Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Dallas Formulations Private Limited

Charges
22 Apr 2025
A charge registered on 17 Aug 2011 via Charge ID 10302287 with Dir. Of Industries With Parri Passu Sbi Baddi was fully satisfied on 22 Apr 2025.
Activity
30 Sep 2024
Dallas Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Dallas Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Charges
15 May 2023
A charge with State Bank Of India of Rs. 266.00 Lakh registered on 11 Nov 2006 with Charge ID 10030257 was modified on 15 May 2023.
Directors
21 Jul 2022
Mukesh Kumar was appointed as a Whole-time director on 21 Jul 2022 & has been associated with this company since 4 years 29 days.
Charges
29 Oct 2014
A charge registered on 28 Nov 2013 via Charge ID 10466437 with Ing Vysya Bank Limited was fully satisfied on 29 Oct 2014.

Frequently Asked Questions about Dallas Formulations Private Limited

Dallas Formulations Private Limited is an active private limited company in the pharma sector based in Ujjain, Madhya Pradesh, India. It was incorporated on 24 November 2000 (26+ years old) and is registered under CIN U24233MP2000PTC014476. The company has 22 employees.

Dallas Formulations Private Limited reported revenue of ₹10.53 Cr for FY 2025 (up 47.00% YoY).

The current directors of Dallas Formulations Private Limited are:

The primary industry of Dallas Formulations Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Dallas Formulations Private Limited can be reached at the registered office: 220 Block – C 2Nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010, or through the website dallaspharma.com.

The authorised capital is ₹50 Lakh, and the paid-up capital is ₹39.09 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available